ARCPOINT PROVIDES LEADERSHIP UPDATE

Article content

GREENVILLE, South Carolina, July 24, 2026 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces today that Peter Kendall has stepped down as Interim Chief Executive Officer of the Company, having completed his mandate and delivered his assessment and recommendations to the Board of Directors. Mr. Kendall was appointed Interim Chief Executive Officer on June 9, 2026 for an initial 90-day term to work with the Board and management to assess the Company’s business model, its MyARCpointLabs (“MAPL”) technology platform, commercial relationships, assets and strategic direction, and to provide recommendations to the Board on commercial and financial paths forward. The Board is now considering those recommendations as it determines the Company’s next steps.

Article content

Article content

The Board thanks Mr. Kendall for his contributions to the Company and will seek to appoint a new Chief Executive Officer as soon as practically possible.

Article content

Article content

Article content

As announced on June 9, 2026, the Company agreed to grant 4,000,000 restricted share units (“RSUs”) to Mr. Kendall. In connection with the conclusion of his engagement, the number of RSUs granted has been pro-rated to reflect the portion of the 90-day term served, and has accordingly been reduced from 4,000,000 to 2,000,000 RSUs. Each RSU entitles the holder to receive one Class A Subordinate Voting Share of the Company upon vesting, which is scheduled to occur on the date that is 12 months following June 9, 2026. RSU grants are under the Company’s omnibus security-based compensation plan and are subject to acceptance by the TSX Venture Exchange (the “TSXV” or the “Exchange”), available capacity under the plan, applicable participant limits and other requirements of TSXV Policy 4.4, applicable securities laws and, if required, disinterested shareholder approval. Mr. Kendall will also continue to provide advisory consulting services to the Company, maintaining his eligibility under the plan pending vesting of the RSUs.

Article content

Article content

About ARCpoint Inc.

Article content

ARCpoint is a healthcare technology company that owns and develops MAPL, a multi-tenant software platform for clinical lab ordering, scheduling and results delivery used by laboratories, collection sites and other healthcare service providers in the United States. ARCpoint’s Class A Subordinate Voting Shares trade on the TSX Venture Exchange under the symbol “ARC”.

Article content

For more information, please contact:

Article content

ARCpoint Inc.
Adam Ho, Chief Financial Officer and Director
Phone: (604) 329-1009
E-mail: [email protected]

Article content

Neither the TSX Venture Exchange nor its Regulation Services Provider, as that term is defined in the policies of the TSX Venture Exchange, accepts responsibility for the adequacy or accuracy of this news release.

Article content

Forward-Looking Information

Article content

This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking information relates to future events or future performance and reflects the expectations or beliefs of management of the Company regarding future events. Forward-looking information in this news release includes, without limitation, statements regarding the Board’s consideration of Mr. Kendall’s recommendations and its determination of the Company’s next steps; the continuation of Mr. Kendall’s involvement with the Company in a consulting capacity; the grant, vesting and settlement of the RSUs; and the receipt of any required acceptances, approvals or capacity in respect of the RSUs.